Do you have dry macular degeneration (AMD)?

evaluating ORACEA® (40 mg doxycycline) for macular degeneration.

Who is eligible for this clinical trial?

You may qualify for this study if:

  • You are at least 55 years of age

  • You have geographic atrophy (advanced dry macular degeneration) in at least one eye

What will happen if I am in this clinical trial?

Participation in this study requires 8 visits and 4 telephone calls over about 31 months. Eligible paricipants are randomly assigned (like the flip of a coin) to take either ORACEA® (40 mg doxycycline) or placebo once daily for 24 months.

Contact Us

For more information about the study, click here or click the envelope icon below.

contact

The following clinics are participating in this study:

▲ Hide locations

▲ Hide locations